Lazard Asset Management LLC Zoetis Inc. Transaction History

Lazard Asset Management LLC

$58.2 Billion
Q1 2025

A detailed history of Lazard Asset Management LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 2,607,553 shares of ZTS stock, worth $444 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

2,607,553

Previous 2,661,639 2.03%

Holding current value

$444 Million

Previous $434 Million 1.0%

% of portfolio

0.74%

Previous 0.7%

48 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$156.48 - $175.67 $8.46 Million - $9.5 Million	-54,086 Reduced 2.03%	2,607,553 $429 Million
Q4 2024 Feb 14, 2025	SELL	$162.24 - $194.42 $33 Million - $39.6 Million	-203,555 Reduced 7.1%	2,661,639 $434 Million
Q3 2024 Nov 14, 2024	SELL	$172.58 - $196.48 $69 Million - $78.6 Million	-399,789 Reduced 12.24%	2,865,194 $560 Million
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $71.6 Million - $88 Million	492,084 Added 17.75%	3,264,983 $566 Million
Q1 2024 May 14, 2024	SELL	$165.67 - $199.94 $12.8 Million - $15.5 Million	-77,343 Reduced 2.71%	2,772,899 $469 Million
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $6.96 Million - $9.2 Million	45,984 Added 1.64%	2,850,242 $563 Million
Q3 2023 Nov 14, 2023	SELL	$167.14 - $192.77 $2.33 Million - $2.69 Million	-13,943 Reduced 0.49%	2,804,258 $488 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $12 Million - $13.9 Million	74,652 Added 2.72%	2,818,201 $485 Million
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $8.78 Million - $10.6 Million	-60,352 Reduced 2.15%	2,743,549 $457 Million
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $18.9 Million - $22.8 Million	-144,501 Reduced 4.9%	2,803,901 $411 Million
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $4.18 Million - $5.14 Million	-28,157 Reduced 0.95%	2,948,402 $437 Million
Q2 2022 Aug 09, 2022	SELL	$155.97 - $200.09 $56.3 Million - $72.3 Million	-361,227 Reduced 10.82%	2,976,559 $512 Million
Q1 2022 May 13, 2022	SELL	$181.39 - $234.03 $28 Million - $36.2 Million	-154,491 Reduced 4.42%	3,337,786 $629 Million
Q4 2021 Feb 09, 2022	SELL	$193.69 - $247.03 $31.8 Million - $40.6 Million	-164,229 Reduced 4.49%	3,492,277 $852 Million
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $4.45 Million - $4.93 Million	-23,526 Reduced 0.64%	3,656,506 $710 Million
Q2 2021 Aug 12, 2021	BUY	$155.9 - $187.99 $16.8 Million - $20.3 Million	108,052 Added 3.02%	3,680,032 $686 Million
Q1 2021 May 14, 2021	BUY	$144.0 - $169.39 $12.8 Million - $15 Million	88,584 Added 2.54%	3,571,980 $563 Million
Q4 2020 Feb 11, 2021	BUY	$157.07 - $174.35 $13.9 Million - $15.4 Million	88,491 Added 2.61%	3,483,396 $576 Million
Q3 2020 Nov 13, 2020	BUY	$137.1 - $165.37 $41.9 Million - $50.6 Million	305,899 Added 9.9%	3,394,905 $561 Million
Q2 2020 Aug 13, 2020	BUY	$111.92 - $142.53 $32.6 Million - $41.6 Million	291,689 Added 10.43%	3,089,006 $423 Million
Q1 2020 May 14, 2020	SELL	$92.66 - $144.94 $14.4 Million - $22.5 Million	-155,479 Reduced 5.27%	2,797,317 $329 Million
Q4 2019 Feb 13, 2020	BUY	$116.25 - $133.25 $4.1 Million - $4.69 Million	35,227 Added 1.21%	2,952,796 $391 Million
Q3 2019 Nov 14, 2019	SELL	$112.57 - $128.43 $75.5 Million - $86.2 Million	-670,940 Reduced 18.7%	2,917,569 $363 Million
Q2 2019 Aug 14, 2019	SELL	$97.98 - $114.28 $38.5 Million - $45 Million	-393,340 Reduced 9.88%	3,588,509 $407 Million
Q1 2019 Aug 28, 2019	SELL	$81.56 - $100.67 $15,496 - $19,127	-190 Reduced -0.0%	3,981,849 $401 Million
Q1 2019 May 13, 2019	SELL	$81.56 - $100.67 $28.8 Million - $35.5 Million	-352,537 Reduced 8.13%	3,982,039 $401 Million
Q4 2018 Aug 28, 2019	BUY	$79.28 - $95.27 $21.1 Million - $25.4 Million	266,613 Added 6.55%	4,334,576 $371 Million
Q4 2018 Feb 13, 2019	SELL	$79.28 - $95.27 $44.2 Million - $53.1 Million	-557,633 Reduced 12.06%	4,067,963 $348 Million
Q3 2018 Aug 30, 2019	BUY	$83.5 - $93.23 $22.6 Million - $25.2 Million	270,484 Added 6.21%	4,625,596 $424 Million
Q3 2018 Nov 13, 2018	SELL	$83.5 - $93.23 $18.5 Million - $20.6 Million	-221,002 Reduced 4.83%	4,355,112 $399 Million
Q2 2018 Aug 30, 2019	BUY	$79.9 - $89.2 $21.7 Million - $24.2 Million	271,132 Added 6.3%	4,576,114 $390 Million
Q2 2018 Aug 13, 2018	SELL	$79.9 - $89.2 $43.3 Million - $48.3 Million	-541,329 Reduced 11.17%	4,304,982 $367 Million
Q1 2018 Aug 28, 2019	BUY	$71.51 - $84.69 $16.3 Million - $19.3 Million	227,350 Added 4.92%	4,846,311 $405 Million
Q1 2018 May 14, 2018	SELL	$71.51 - $84.69 $15.9 Million - $18.8 Million	-221,677 Reduced 4.58%	4,618,961 $386 Million
Q4 2017 Aug 28, 2019	BUY	$63.24 - $72.8 $17.5 Million - $20.1 Million	276,620 Added 6.06%	4,840,638 $349 Million
Q4 2017 Feb 13, 2018	SELL	$63.24 - $72.8 $39 Million - $44.9 Million	-616,282 Reduced 11.9%	4,564,018 $329 Million
Q3 2017 Aug 19, 2019	BUY	$59.73 - $65.4 $16.8 Million - $18.4 Million	280,826 Added 5.73%	5,180,300 $330 Million
Q3 2017 Nov 13, 2017	SELL	$59.73 - $65.4 $169 Million - $185 Million	-2,834,545 Reduced 36.65%	4,899,474 $312 Million
Q2 2017 Aug 19, 2019	SELL	N/A	-2,286,161 Reduced 22.82%	7,734,019 $482 Million
Q1 2017 Aug 13, 2019	SELL	N/A	-10,036,265 Reduced 50.04%	10,020,180 $535 Million
Q4 2016 Jul 30, 2019	BUY	N/A	512,990 Added 2.62%	20,056,445 $1.07 Billion
Q3 2016 Aug 07, 2019	SELL	N/A	-2,494,871 Reduced 11.32%	19,543,455 $1.02 Billion
Q2 2016 Jul 29, 2019	BUY	N/A	1,897,410 Added 9.42%	22,038,326 $1.05 Billion
Q1 2016 Jul 25, 2019	BUY	N/A	1,020,563 Added 5.34%	20,140,916 $893 Million
Q4 2015 Jul 24, 2019	SELL	N/A	-564,113 Reduced 2.87%	19,120,353 $916 Million
Q3 2015 Jul 15, 2019	BUY	N/A	3,993,149 Added 25.45%	19,684,466 $811 Million
Q2 2015 Jul 08, 2019	SELL	N/A	-911,343 Reduced 5.49%	15,691,317 $757 Million
Q4 2014 Aug 29, 2019	BUY	N/A	16,602,660	16,602,660 $714 Million

Others Institutions Holding ZTS

# of Institutions

2,112

Shares Held

421M

Call Options Held

1.98M

Put Options Held

1.03M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $79.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Zoetis Inc. Transaction History